GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

GSK PLC GSK shares inched up 0.59% to £13.58 Tuesday, on what proved to be an all-around dismal trading session for the stock ...

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s ...

GSK has gained US Food and Drug Administration (FDA) breakthrough therapy designation (BTD) for its B7-H3-targeted ...

GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased ...

Recent health news includes Donald Trump's consideration of an executive order on gas stoves, Roche's acquisition of Poseida, ...

The FDA bestows a Breakthrough Therapy designation to GSK's antibody-drug conjugate, GSK5764227, for treating relapsed or refractory osteosarcoma.

Range Financial Group LLC acquired a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange ...

In a report released today, James Gordon from J.P. Morgan reiterated a Sell rating on GlaxoSmithKline (GSK – Research Report). The company’s ...

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...